金徽酒(603919.SH):共計9900.908萬股接受海南豫珠發出的要約
格隆匯 10 月 19日丨金徽酒(603919.SH)公佈,根據中國證券登記結算有限責任公司上海分公司提供的數據統計,2020年9月16日至2020年10月15日要約收購期間,最終有11個賬户,共計9900.908萬股股份接受海南豫珠發出的要約。
海南豫珠將按照《金徽酒股份有限公司要約收購報告書》的要約收購條件購買4058.08萬股公司股份,過户手續將根據相關規定辦理。根據《公司法》的規定,此次要約收購完成後,金徽酒的股權分佈仍符合上市條件,上市地位不受影響。
此次要約收購完成後,公司控股股東豫園股份及其一致行動人海南豫珠合計持有公司股份192,758,700股,佔公司總股本的38%。
公司股票自2020年10月19日開市起復牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.